Read More Healthcare Industry News SN share price firms as Smith+Nephew launches $500m buyback and Cevian Capital adds to 5% activist stake Cevian wants a breakup. Deepak Nath wants RISE to deliver. The $500m buyback is the bridge. H2 2026 is where the real test of the Smith+Nephew thesis lands. byVenkateshMay 16, 2026